Embryo Health Study
Recruiting now
Conditions studied: Infertility, Hereditary Diseases
In brief
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Key facts
- Study ID
- NCT04528498
- Run by
- Genomic Prediction Inc.
- People needed
- 500
- Starts
- 2020-12-01
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-08-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All couples of Caucasian or East Asian ancestry above the age of 18 who elect to have PGT-A as part of their IVF treatment cycle.
You may not qualify if…
- Any case where biological parental DNA is unavailable.
- Any case involving PGT-M or PGT-SR.
Where it is running
- Genomic Prediction Clinical Laboratory — North Brunswick, New Jersey, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.